Upon completion of this educational activity, participants will be able to:

1.     Compare evidence-based pharmacotherapies for opioid and alcohol use disorders to determine appropriate selection based on patient-specific factors.

2.     Demonstrate person-first, non-stigmatizing language in clinical documentation and communication.

3.     Develop practical strategies for medication continuity during care transitions.

This session is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.) Number of hours: 1

This session is designed to meet the Wisconsin MEB requirements for continuing education on prescribing opioids and other controlled substances. Number of Credits: 1

 

Session date: 
05/21/2026 - 12:00pm to 1:00pm CDT
Location: 
Virtually
WI
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
  • 1.00 ANCC Contact Hours
    • 1.00 Wisconsin Responsible Opioid Prescribing Credit
    • 1.00 ANCC Pharmacotherapy Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Maggie Willliams, PA